Our Pipeline
Our Pipeline
Our diverse pipeline of novel regenerative medicine candidates is being advanced to deliver first-in-class therapeutics in areas with high unmet need in ophthalmology and tissue regeneration.
Our diverse pipeline of novel regenerative medicine candidates is being advanced to deliver first-in-class therapeutics in areas with high unmet need in ophthalmology and tissue regeneration.
Our Pipeline
Our Pipeline
Our Pipeline
Therapeutic
Therapeutic
Technology
Technology
Indication
Indication
Pre-clinical
Pre-clinical
Phase 1
Phase 1
Phase 2
Phase 2
Phase 3
Phase 3
Registration
Registration
Elate Ocular
Elate Ocular
HPL
HPL
Dry Eye Disease
Dry Eye Disease
Progenza
Progenza
MSC & Secretome
MSC & Secretome
Knee Osteoarthritis
Knee Osteoarthritis
Sygenus
Sygenus
Secretome
Secretome
Wound Healing
Wound Healing
Technology: HPL
Indication: Dry Eye Disease
Stage: Phase 2
Elate Ocular
Technology: MSC & Secretome
Indication: Knee Osteoarthritis
Stage: Phase 1
Progenza
Technology: Secretome
Indication: Wound Healing
Stage: Preclinical
Sygenus
Publications
Publications
Publications
Sugar, A. et al. (2022). A randomized trial of topical Fibrinogen-Depleted human platelet lysate treatment of dry eye secondary to chronic Graft-Versus-Host disease. Ophthalmology Science.
Sugar, A. et al. (2022). A randomized trial of topical Fibrinogen-Depleted human platelet lysate treatment of dry eye secondary to chronic Graft-Versus-Host disease. Ophthalmology Science.
Sugar, A. et al. (2022). A randomized trial of topical Fibrinogen-Depleted human platelet lysate treatment of dry eye secondary to chronic Graft-Versus-Host disease. Ophthalmology Science.
Kuah, D.et al. (2018). Safety, tolerability and efficacy of intra-articular Progenza in knee osteoarthritis: a randomized double-blind placebo-controlled single ascending dose study. Journal of Translational Medicine.
Kuah, D.et al. (2018). Safety, tolerability and efficacy of intra-articular Progenza in knee osteoarthritis: a randomized double-blind placebo-controlled single ascending dose study. Journal of Translational Medicine.
Kuah, D.et al. (2018). Safety, tolerability and efficacy of intra-articular Progenza in knee osteoarthritis: a randomized double-blind placebo-controlled single ascending dose study. Journal of Translational Medicine.